{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:09:17Z","timestamp":1789506557214,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.pnpbp.2011.04.006","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T01:07:25Z","timestamp":1303693645000},"page":"1303-1308","source":"Crossref","is-referenced-by-count":17,"title":["The impact of glycogen synthase kinase 3\u03b2 gene on psychotic mania in bipolar disorder patients"],"prefix":"10.1016","volume":"35","author":[{"given":"Youn-Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.04.006_bb0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2004.11.036","article-title":"Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum","volume":"57","author":"Alimohamad","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0010","series-title":"Diagnostic and statstical manual of mental disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-3223(02)01320-3","article-title":"Genome scan for susceptibility loci for schizophrenia and bipolar disorder","volume":"52","author":"Bailer","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1600-0447.1981.tb00796.x","article-title":"Age-of-onset and genetic transmission in affective disorders","volume":"64","author":"Baron","year":"1981","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0025","first-page":"118","article-title":"The BPRS: psychometric developments","volume":"24","author":"Bech","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2003.10.021","article-title":"A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder","volume":"355","author":"Benedetti","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0035","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0040","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0045","series-title":"Structured clinical interview for DSM-IV axis I disorder-patient edition (SCID-I\/NP, version 2.0)","author":"First","year":"1998"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00852-8","article-title":"Prenatal cocaine exposure alters glycogen synthase kinase-3beta (GSK3beta) pathway in select rabbit brain areas","volume":"349","author":"Gil","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0055","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2001.00495.x","article-title":"CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium","volume":"78","author":"Grimes","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s001250050771","article-title":"Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM","volume":"40","author":"Hansen","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopsych.2004.07.023","article-title":"Association of AKT1 with schizophrenia confirmed in a Japanese population","volume":"56","author":"Ikeda","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajmg.b.30155","article-title":"No association of GSK3beta gene (GSK3B) with Japanese schizophrenia","volume":"134B","author":"Ikeda","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0080","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1242\/jcs.01562","article-title":"Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3","volume":"118","author":"Kim","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0090","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2005.10.059","article-title":"No association of two common SNPs at position \u22121727 A\/T, \u221250C\/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population","volume":"395","author":"Lee","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0100","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s007020050235","article-title":"Glycogen synthase kinase-3 beta, beta-catenin, and tau in postmortem bipolar brain","volume":"106","author":"Lesort","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0105","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(90)90385-R","article-title":"The Wnt-1(int-1) proto-oncogene is required for development of a large region of the mouse brain","volume":"62","author":"McMahon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2005.10.042","article-title":"Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder","volume":"394","author":"Nishiguchi","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mp.4000852","article-title":"Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease","volume":"6","author":"Russ","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0120","first-page":"104","article-title":"Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease","volume":"7","author":"Russ","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YPG.0b013e328013d8d8","article-title":"Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder","volume":"17","author":"Scassellati","year":"2007","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.psychres.2007.06.017","article-title":"Association between GSK-3 beta-50T\/C polymorphism and personality and psychotic symptoms in mood disorders","volume":"158","author":"Serretti","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.c.20013","article-title":"Family, twin, and adoption studies of bipolar disorder","volume":"123C","author":"Smoller","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000090704","article-title":"Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder","volume":"53","author":"Szczepankiewicz","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2011.04.006_bb0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:53:11Z","timestamp":1543798391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0278584611001229"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.04.006","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}